Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Common Name: Inhalant Use Disorder
- Medical Term: Inhalant Use, Unspecified, Uncomplicated
Summary
Inhalant use, unspecified, uncomplicated refers to the misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects, without specifying the severity or presence of a disorder. This condition involves the intentional inhalation of substances like glue, paint thinners, or aerosols, which can lead to acute intoxication, dependence, or other substance-related health issues. Inhalant use may result in significant physical and psychological harm, affecting an individual's health and daily functioning.
Causes
Inhalant use is primarily driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to dependence and related health issues.
Risk Factors
- Adolescents and young adults are more likely to experiment with inhalants.
- Individuals with a history of substance abuse or mental health disorders.
- Accessibility to inhalant products.
- Lack of proper supervision or guidance.
Symptoms
- Intense cravings or compulsive inhalant use.
- Coordination problems, dizziness, or lethargy.
- Unexplained behavioral changes such as aggression or mood swings.
- Cognitive impairment or memory issues.
Diagnosis
Clinical evaluation including a detailed history of inhalant use, physical examination, and assessment of symptoms. Laboratory tests may be used to rule out other conditions or detect substance-related effects.
Treatment Options
Treatment may involve behavioral therapy, counseling, and support groups to address dependence and underlying issues. In some cases, medication may be used to manage withdrawal symptoms or co-occurring mental health conditions.
Prognosis and Follow-Up
Prognosis depends on the severity of use and individual factors. Regular follow-up is important to monitor progress, address relapse risks, and adjust treatment as needed.
Complications
- Respiratory damage or failure.
- Neurological impairment, including cognitive decline.
- Organ damage, particularly to the liver or kidneys.
- Increased risk of accidents or injuries due to impaired coordination.
Lifestyle & Prevention
- Avoiding exposure to inhalant products.
- Educating at-risk individuals about the dangers of inhalant use.
- Providing alternative coping strategies for stress or peer pressure.
- Ensuring proper supervision of children and adolescents.
When to Seek Professional Help
Seek help if inhalant use is causing physical or psychological harm, interfering with daily life, or leading to dependence. Signs may include uncontrolled use, withdrawal symptoms, or worsening health issues.
Tips for Medical Coders
Document the specific inhalant used, if known, and whether the use is uncomplicated (no associated disorders or complications). Ensure the diagnosis aligns with clinical findings and supports the use of F18.90.
F18.90 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.